Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 11 - 08 save search
Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations
Published: 2021-11-08 (Crawled : 23:00) - globenewswire.com
APRE | $5.815 -1.44% 1.6K
|
Health Technology
|
| O: 0.6%
H: 4.14%
C: -0.39%
financial results results
Rubius Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-08 (Crawled : 23:00) - globenewswire.com
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 4.0%
H: 6.58%
C: -0.39%
financial results results
Gyroscope Therapeutics Announces Sanofi Investment of Up to $60 Million
Published: 2021-11-08 (Crawled : 22:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
therapeutics
Janux Therapeutics to Present Virtually at Upcoming Investor Conferences
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
JANX | $51.485 -0.72% 330K
|
Professional, Scientific, and T...
|
| O: 1.76%
H: 6.19%
C: -12.63%
conference therapeutics
Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
TPST | $3.34 -6.96% 260K
|
Manufacturing
|
| O: -2.05%
H: 2.24%
C: 1.67%
pest patent
RAPT Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
RAPT | $8.11 -5.04% 350K
|
Health Technology
|
| O: 0.76%
H: 0.18%
C: -3.14%
conference therapeutics
Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
APVO 3 d | $0.7694 -1.74% 450K
|
Health Technology
|
| O: -1.21%
H: 1.22%
C: -6.84%
trial initiated bioscience
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
SEEL | $0.3925 -9.98% 310K
|
Health Technology
|
| O: 0.9%
H: 4.04%
C: 2.69%
new drug fast track designation treatment fda fda acceptance application fast track drug designation
Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: -1.07%
H: 2.71%
C: -10.36%
gene therapy therapy
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BCLI | $0.5325 -2.95% 500K
|
Health Technology
|
| O: 0.0%
H: 0.97%
C: -1.61%
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 InhibitorPhase 1 Clinical Trial in Patients with Selected Solid Tumors Anticipated to Begin by Year-End
Published: 2021-11-08 (Crawled : 15:00) - biospace.com/
PRLD | $5.57 -1.07% 9.8K
|
Health Technology
|
| O: 1.69%
H: 1.49%
C: -0.4%
solid tumors phase 1 trial clearance
Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors
Published: 2021-11-08 (Crawled : 15:00) - globenewswire.com
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ATRX | $0.008 150K
|
Manufacturing
|
| O: 6.26%
H: 0.0%
C: -5.89%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 10 Million Shares of its Common Stock
Published: 2021-11-08 (Crawled : 14:15) - biospace.com/
CORT M | $23.48 1.43% 240K
|
Health Technology
|
| O: 8.08%
H: 4.61%
C: 2.42%
Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
CTS | $44.72 -1.65% 42K
|
Electronic Technology
|
| O: 0.13%
H: 1.91%
C: -0.05%
treatment cancer ceo liver platform t-cell
DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
DMAC | $2.39 13K
|
Health Technology
|
| O: 2.8%
H: 0.42%
C: -3.77%
stroke phase 2 phase 2/3 trial
Diamond Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Low-Dose Psilocybin
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
ARMV | $0.005 2214.82% 300
|
| Email alert
Add to watchlist
trial psilocybin
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published: 2021-11-08 (Crawled : 13:15) - ir.hoththerapeutics.com
HOTH | $1.18 -1.67% 47K
|
Health Technology
|
| O: -0.91%
H: 3.67%
C: 1.83%
cancer contract drug
Jasper Therapeutics to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
JSPR | $24.77 -5.82% 51K
|
|
| O: 0.0%
H: 3.14%
C: 0.66%
conference
Keros Therapeutics to Present Results from a Preclinical Study of RKER-012 at the American Heart Association 2021 Scientific Sessions
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
KROS | $57.99 0.54% 69K
|
Health Technology
|
| O: 3.82%
H: 2.5%
C: 1.94%
heart results preclinical pre-clinical
Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 23.0%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.